Clinical and financial outcomes of switching insulin glargine to insulin detemir in a veteran population with type 2 diabetes

Conclusion The increase in A1c and TDD following conversion from insulin glargine to insulin detemir suggests that glargine requires a smaller amount of units to reach the same glycemic-lowering ability compared to detemir. Despite the observed insulin cost savings associated with detemir, future studies should also determine overall costs (including indirect) and benefits associated with switching from glargine to detemir among Veteran with Type 2 diabetes.
Source: Journal of Diabetes and Metabolic Disorders - Category: Endocrinology Source Type: research